Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
RTC
0.00%
0.0¢
RESIMAC TRIOMPHE TRUST PREMIER 2017-2 - Announcements
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
RTC | Admission to Official List | PRICE SENSITIVE | 11/09/17 | |
RTC Admission to Official List | |||
11/09/17 | PRICE SENSITIVE | ||